CompletedNCT01649895
D-Cycloserine Added to Online CBT for OCD
About this title
Read the official source — NCT01649895Medication studyAges 18–100Sweden
Understand this study
Who was this study for?
Listed age limits: 18 years to 100 years.
- Listed locations
- StockholmSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 128
- Sponsor
- Christian Rück
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Sweden
- Age range
- From 18 Years to 100 Years
- Official registry ID
- NCT01649895
- Official title
Show the full official title
Internet-based Cognitive Behavior Therapy in Combination With D-Cycloserine for Obsessive Compulsive Disorder: A Double Blinded Randomized Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedStockholm
Questions about this study
Who is behind this study?
The study sponsor is Christian Rück.
Did this study involve medication?
Yes. The study involved medication, including D-Cycloserine and Placebo.
Who was this study for?
Listed age limits: 18 years to 100 years.
Want to explore more studies?
Explore studiesRelated studies
Eficacia de agomelatina 25mg/día (con posibilidad de incremento a 50mg/día tras 8 semanas de tratamiento) por vía oral durante 16 semanas en pacientes con Trastorno Obsesivo Compulsivo // Efficacy...
Internet-based cognitive behavior therapy in combination with D-Cycloserine for OCD: A double blinded randomized controlled trial